Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Practical information: transition to the new directorate

Published:

|

Updated:

Changes

  • : Added information regarding requirements for updating product information about medicines.
  • : Added requirements for updating product information about medicines
  • : Changed information regarding requirements for updating product information about medicines
  • : Added information regarding requirements for updating product information about medicines

The Norwegian Medicines Agency will have increased responsibilities and become the Norwegian Medical Products Agency (NOMA) from January 1st, 2024.

You can read more about the change here.

If you have any questions, please contact redaksjonen@noma.no 

Practical information - what's new

  • Name: We kindly request that you change our name on invoices, letters, and text on websites, presentations, and other materials from 01.01.24. The invoice address, postal address, phone number, and visiting and delivery address will remain unchanged. The new logo will be made public on January 1st.
  • Website address: www.legemiddelverket.no will change its name to www.dmp.no. The URLs www.legemiddelverket.no and www.dmp.no will redirect to each other so that links will work during a transitional period. However, we encourage external parties to update links pointing to information on our website as soon as possible after 01.01.2024. 
  • Email addresses: All of our email addresses will change from @legemiddelverket.no to @dmp.no, while @noma.no will still work. There will also be a transitional period for email addresses, similar to the website address. We kindly request that email addresses be updated as soon as possible after 01.01.2024. 

Updating product information about medicines

Human medicinal products

The section for reporting side effects in the Summary of Product Characteristics (section 4.8) and the package leaflet (section 4) needs to be updated. Instructions on how to implement this can be found on this page.

Educational material

Educational material must be updated so that name, links and safety logo are correct. Updated educational material shall not be sent to us, as the changes are not significant. We request that the material be updated by 1.1.2025.

Veterinary medicinal products

The section for reporting side effects (introduced in QRD template version 9) needs to be updated. Instructions on how to implement this can be found on this page.

Contact us

Unit for communication

+47 485 09 554

redaksjonen@noma.no